Radiotherapy-induced ocular surface disease

Cornea

Volumn 24, Issue 8, 2005, Pages 909-914

  Barabino, Stefano ^a,b   Raghavan, Anita ^a   Loeffler, Jay ^c   Dana, Reza ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brachytherapy; Fractionation; Ocular surface; Teletherapy

Indexed keywords

CONJUNCTIVA DISEASE; CORNEA DISEASE; EYE DISEASE; EYELID DISEASE; HUMAN; HYPERPIGMENTATION; LACRIMAL GLAND DISEASE; PRIORITY JOURNAL; PUNCTATE KERATITIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PROTECTION; RADIOTHERAPY; SHORT SURVEY;

EYE; EYE DISEASES; EYE NEOPLASMS; HUMANS; RADIATION INJURIES; RADIOTHERAPY; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 28044461079     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000154235.64359.d3     Document Type: Short Survey

References (44)

1. 909-914 1. Chalupecky H. Ueber die Wirkung der Röntgenstrahlen auf das Auge und die Haut. Zentralbl Augenheilkd. 1897;21:234-239.
2. Birch-Hirschfeld GVA. Zur Wirkung der Röntgenstrahlen auf das Menschliche Auge. Klin Mbl Augenheilkd. 1908;46:129-137.
3. Stallard HB. Radiation energy as pathogenic and therapeutic agent in ophthalmic disorders. Br J Ophthalmol. 1933;(suppl.6):64-70.
4. Lavey RS, Poen JC. Principles of radiation oncology. In: Cameron RB, ed. Practical Oncology. Norwalk, CT: Appleton & Lange, 1994, pp 17-21.
5. Hall EJ, Cox JD. Physical and biologic basis of radiation therapy. In: Cox JD, ed. Moss' Radiation Oncology: Rationale, Techniques, Results. St Louis: Mosby, 1994, pp 3-66.
6. Fitzpatrick PJ, Thompson GA, Easterbrook WM, et al. Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radiat Oncol Biol Phys. 1984;10:449-454.
7. Pardo FS, Wang CC, Albert D, et al. Sebaceous carcinoma of the ocular adnexa: radiotherapeutic management. Int J Radiat Oncol Biol Phys. 1989; 17:643-647.
8. Pelloski CE, Wilder RB, Ha CS, et al. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol. 2001;59:145-151.
9. Blach LE, McCormick B, Abramson DH. External beam radiation therapy and retinoblastoma: long term results in the comparison of two techniques. Int J Radiat Oncol Biol Phys. 1996;35:45-51.
10. Merchant TE, Gould CJ, Wilson MW, et al. Episcleral plaque brachytherapy for retinoblastoma. Pediatr Blood Cancer. 2004;43:134-139.
11. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings: COMS report No. 18. Arch Ophthalmol. 2001;119:969-982.
12. Rouberol F, Roy P, Kodjikian L, et al. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol. 2004;137:893-900.
13. Kodjikian L, Roy P, Rouberol F, et al. Survival after proton.beam irradiation of uveal melanomas. Am J Ophthalmol. 2004;137:1002-1010.
14. Zeck OF. Dosimetry of Iodine-125 seeds in eye plaques: technical note. Cancer Bull. 1992;44:366-367.
15. Rubin P, Constine LS, Fajardo LF, et al. RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys. 1995;31:1041-1042.
16. Gordon KB, Char DH, Sagerman RH. Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys. 1995;31:1123-1139.
17. Brady LW, Shields J, Augusburger J, et al. Complications from radiation therapy to the eye. Front Radiat Ther Oncol. 1989;23:238-250.
18. Nakissa N, Rubin R, Strahl R, et al. Ocular and orbital complications following radiation therapy of paranasal sinus malignancies and review of literature. Cancer. 1983;51:980-986.
19. Gragoudas ES, Goitein M, Verhey L, et al. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology. 1980; 87:571-581.
20. Pilapil F, Studva KV, Dietz KA. Programmed instruction: cancer care. Radiation therapy: external radiation. Cancer Nurs. 1979;2:129-138.
21. Roth J, Brown N, Catterall M, et al. Effects of fast neutrons on the eye. Br J Ophthalmol. 1976;60:236-244.
22. Karp LA, Streeten BW, Cogan DG. Radiation-induced atrophy of the Meibomian gland. Arch Ophthalmol. 1979;97:303-305.
23. Kwok SK, Ho PC, Leung SF, et al. An analysis of the incidence and risk factors of developing severe keratopathy in eyes after megavoltage external beam irradiation. Ophthalmology. 1998;105:2051-2055.
24. Monta K, Kawabe Y. Late effects on the eye of conformation radiotherapy for carcinoma of the paranasal sinuses and nasal cavity. Radiology. 1979; 130:227-232.
25. Parsons JT, Bova FJ, Fitzgerald CR, et al. Severe dry-eye syndrome following external beam irradiation. Int J Radiat Oncol Biol Phys. 1994; 30:775-780.
26. Parsons JT, Fitzgerald CR, Hood CI, et al. The effects of irradiation on the eye and optic nerve. Int J Radiat Oncol Biol Phys. 1983;9:609-622.
27. Bessell EM, Henk JM, Whitelocke RA, et al. Ocular morbidity after radiotherapy of orbital and conjunctival lymphoma. Eye. 1987;1:90-96.
28. Eter N, Schüller H. External beam radiotherapy for age-related macular degeneration causes transient objective changes in tear-film function. Graefes Arch Clin Exp Ophthalmol. 2001;239:923-926.
29. Merriam GR, Szechter A, Focht EF. The effect of ionizing radiations on the eye. Front Radiat Ther Oncol. 1972;6:346-385.
30. Gerber DS, Campo RV Acute and chronic keratitis with ulceration after corneal exposure to helium ion irradiation. Am J Ophthalmol. 1987;104: 189-190.
31. Stafford SL, Kozelsky TF, Garrity JA, et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol. 2001;59: 139-144.
32. Dua HS, Joseph A, Shanmuganathan VA, et al. Stem cell differentiation and the effects of deficiency. Eye. 2003;17:877-885.
33. Oinaka M. Experimental investigations of the late effects of ionising radiation on the cornea. Histopathological study. Nippon Ganka Gakkai Zasshi. 1980;84:2004-2019.
34. Fujishima H, Shimazaki J, Tsubota K. Temporary corneal stem cell dysfunction after radiation therapy. Br J Ophthalmol. 1996;80:911-914.
35. Smith GT, Deutsch GP, Cree IA, et al. Permanent corneal limbal stem cell dysfunction following radiotherapy for orbital lymphoma. Eye. 2000;14: 905-907.
36. Bahrassa F, Datta R. Postoperative beta radiation treatment of pterygium. Int J Radiat Oncol Biol Phys. 1983;9:679-684.
37. Foster CS. Corneal manifestations of neurological diseases. In: Smolin G, Thoft RA, eds. The Cornea: Scientific Foundation and Clinical Practice. Boston: Little, Brown, 1994, 485-498.
38. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology. 2001;108: 586-592.
39. Fleck R, McNeese MD, Ellerbroek NA, et al. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys. 1989;17:829-833.
40. Berson AM, Quivey JM, Harris JW, et al. Radiation therapy for AIDS-related Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1990;19:569-575.
41. Bull JM, Ruiz RS. Ocular complications of systemic cancer therapy. Cancer Bull. 1992;44:395-403.
42. Parsons JT, Bova FJ, Mendenhall WM, et al. Response of the normal eye to high dose radiotherapy. Oncology. 1996;10:837-847.
43. Servodidio CA, Abramson DH. Acute and long-term effects of radiation therapy to the eye in children. Cancer Nurs. 1993;16:371-381.
44. Ingraham HJ, Perry HD, Donnenfeld ED, et al. Glued-on, rigid gaspermeable contact lens for severe radiation-induced keratitis. Am J Ophthalmol. 1992;113:538-540.